Monday, July 18, 2011

SARcode Bioscience nabs $44M second-round funding

SARcode Bioscience Inc., a Brisbane company developing eye treatments, raised $44 million in a second round of funding led by Sofinnova Ventures.
SARcode said it plans to use proceeds of the new funding for clinical development of a treatment for dry-eye syndrome.

No comments:

Post a Comment